Senseonics Holdings (SENS) Gains from Investment Securities (2014 - 2026)
Senseonics Holdings (SENS) reported Gains from Investment Securities of $150000.0 for Q1 2026, down 98.4% year-over-year from $9.4 million in Q1 2025, and up 113.99% quarter-over-quarter from -$1.1 million in Q4 2025.
Senseonics Holdings (SENS) Gains from Investment Securities (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Gains from Investment Securities data on file, last reported at $150000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $150000.0, down 98.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$289000.0 (down 103.08% YoY), and the FY2025 annual result was $1.5 million, up 112.04% from the prior year.
- Gains from Investment Securities advanced to $150000.0 in Q1 2026 per SENS's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $15.7 million in Q1 2023 and troughed at -$1.1 million in Q4 2025.
- A 5-year average of $2.2 million and a median of $823053.5 in 2022 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 85331.82% in 2025 and fell as far as 272.35% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$184000.0 in 2022, then soared by 1258.7% to $2.1 million in 2023, then tumbled by 70.83% to $622000.0 in 2024, then plunged by 272.35% to -$1.1 million in 2025, then soared by 113.99% to $150000.0 in 2026.
- Business Quant data shows SENS's Gains from Investment Securities at $150000.0 in Q1 2026, -$1.1 million in Q4 2025, and $315375.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 329.46 Mn | 265.14 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | 315,375.00 |
| Sep 30, 2025 | 315,375.00 |
| Jun 30, 2025 | 683,312.00 |
| Jun 30, 2025 | 683,312.00 |
| Mar 31, 2025 | 9.40 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Dec 31, 2024 | 622,000.00 |
| Dec 31, 2024 | 622,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Sep 30, 2023 | 2.13 Mn |
| Sep 30, 2023 | 2.13 Mn |